1. Home
  2. SCNI vs CRIS Comparison

SCNI vs CRIS Comparison

Compare SCNI & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scinai Immunotherapeutics Ltd.

SCNI

Scinai Immunotherapeutics Ltd.

N/A

Current Price

$1.55

Market Cap

1.2M

Sector

Health Care

ML Signal

N/A

Logo Curis Inc.

CRIS

Curis Inc.

N/A

Current Price

$0.47

Market Cap

976.1K

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCNI
CRIS
Founded
2003
2000
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2M
976.1K
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
SCNI
CRIS
Price
$1.55
$0.47
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $30.33
AVG Volume (30 Days)
103.0K
★ 5.9M
Earning Date
08-24-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
★ 91.57
EPS
★ N/A
N/A
Revenue
N/A
★ $9,898,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$604.76
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 31.50
52 Week Low
$0.21
$0.33
52 Week High
$3.58
$2,880.00

Technical Indicators

Market Signals
Indicator
SCNI
CRIS
Relative Strength Index (RSI) 77.95 33.16
Support Level $1.43 $0.33
Resistance Level $1.76 $1.60
Average True Range (ATR) 0.08 0.21
MACD 0.10 0.15
Stochastic Oscillator 93.78 7.04

Price Performance

Historical Comparison
SCNI
CRIS

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: